Landscapes / Targets
ROCK2
3 drugs act on ROCK2, in 16 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs3
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Janus kinase inhibitor |
Approved in China | Dec 2026Phase 1/2 trial completes | |||
| How it works | Blocks JAK enzymes that pass on immune signals | ||||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Myelofibrosis, Chronic Graft Versus Host Disease and 1 more | ||||
| Open drug page | |||||
Belumosudilnot checked |
— |
Sanofi · Public SNY |
Approved | 30 Aug 2027Phase 4 trial completes | |
| Next date | 30 Aug 2027 · Phase 4 trial completes | ||||
| Also tested for | Chronic Graft Versus Host Disease, Plasma Cell Myeloma Refractory and 1 more | ||||
| Open drug page | |||||
— |
Phase 2 | Jul 2027Phase 2 trial completes | |||
| Next date | Jul 2027 · Phase 2 trial completes | ||||
| Also tested for | Friedreich's Ataxia | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 2 of 3 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026